The impact of atorvastatin on post-surgery palindromia of traumatic chronic subdural hematoma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017990

Enrollment

Unknown

Registered

2018-08-25

Start date

2018-10-01

Completion date

Unknown

Last updated

2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic chronic subdural hematoma

Interventions

treatment group:take atorvastatin through the mouth

control group:take placebo through the mouth

Eligibility

Sex/Gender

All

Age

60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 60-90 years old; 2. unilateral or bilateral traumatic chronic subdural hematoma need to surgery; 3. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Statin drug allergy or adverse reactions. 2. The patient is in critical condition or the vital signs are unstable. 3. CSDH is caused by tumor, blood disease and other reasons. 4. Abnormal liver function or severe liver disease. 5. Those who are taking statins or who are about to take statins due to disease need; 6. With brain surgery history.

Design outcomes

Primary

Measure	Time frame
hematoma volume;	—

Secondary

Measure	Time frame
ADL-BL score;MGS score;GOS score;	—

Countries

China

Contacts

Public ContactJun Ding

Shanghai Sixth People's Hospital

djdjdoc@126.com+86 18930170457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026